Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in First Complete Remission (CR1) in Addition to FLT3 Inhibition With Quizartinib in Acute Myeloid Leukemia (AML) With FLT3-Internal Tandem Duplication (FLT3-ITD): Results from the QuANTUM-First Trial

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览24
暂无评分
关键词
Allo-HCT, AML, FLT3-ITD, MRD, quizartinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要